Item 2.02. Results of Operations and Financial Condition.
On September 9, 2021, Immuneering Corporation (the "Company") announced its
financial results for the quarter ended June 30, 2021 and provided operational
updates. The full text of the press release issued in connection with the
announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K
(the "Current Report").
The information in this Item 2.02 of this Current Report, including Exhibit
99.1, is intended to be furnished and shall not be deemed "filed" for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), or otherwise subject to the liabilities of that section, nor shall it be
deemed incorporated by reference in any filing under the Securities Act of 1933,
as amended, or the Exchange Act, except as expressly provided by specific
reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
The following exhibits relate to Item 2.02, which shall be deemed to be
furnished, and not filed:
99.1 Press Release issued on September 9, 2021
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source Glimpses